CDH5 and rheumatoid arthritis: Additionally, researchers assessing the relevance of VE-cadherin in RA patients [21, 22] raised the topic of higher risk of cardiovascular events in that population which may be an important confounding factor in analyses regarding VE-cadherin in adult patients.